(IN BRIEF) Covestro has inaugurated a groundbreaking pilot plant at its Leverkusen site, heralding a significant leap in chemical production.…
(IN BRIEF) Evonik has successfully completed its industrial-scale facility for sustainable biosurfactants in Slovakia, becoming the world's first plant to…
(IN BRIEF) The BioSense Institute in Novi Sad has opened a new building offering modern facilities for scientific research and…
(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will…
(IN BRIEF) Bayer has announced the recipients of its 2023 Grants4Ag program, which will provide funding and mentorship to researchers…
(IN BRIEF) Researchers from the Ecole Normale Supérieure in Lyon and the University of Freiburg’s Institute of Physiology have cast…
(IN BRIEF) UK Research and Innovation has launched the Biotech Business Incubation Centre (Bio BIC) in the north-west of England…
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from…
Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorders Transaction adds to Sanofi pipeline a potential…
New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 —…
(PRESS RELEASE) COPENHAGEN, 26-Nov-2020 — /EuropaWire/ — Global biotechnology company Novozymes announces the appointment of Morten Enggaard Rasmussen as Executive…
(PRESS RELEASE) VIENNA, 24-Sep-2020 — /EuropaWire/ — Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical…
CINRYZE is the first and only therapy indicated in the U.S. to help prevent angioedema attacks in pediatric patients with…
New facility will add 30% capacity to Shire’s internal plasma manufacturing network once fully operational Expanded capacity supports continued strong…
Participation in private placement as a cornerstone investor EBRD participates in US$ 51m equivalent private placement of Mabion Mabion is…
Coventry, UK, 08-Jan-2018 — /EuropaWire/ — VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced…
Cordoba, Spain, 12-6-2013 — /europawire.eu/ — VivaCell Biotechnology España S.L., Cordoba, Spain today announced that it has entered into joint Research Collaboration…
Bayer foundation scholarships – EUR 200,000 for work and study abroad Support for ambitious study projects in the fields of…
We are supporting research and development into innovative drug treatments in Hungary 7-5-2013 — /europawire.eu/ — For well over 100 years,…